<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01732432</url>
  </required_header>
  <id_info>
    <org_study_id>210/12</org_study_id>
    <nct_id>NCT01732432</nct_id>
  </id_info>
  <brief_title>Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC)</brief_title>
  <acronym>EAOC</acronym>
  <official_title>Endometriosis and Frequency of Endometriosis-associated Ovarian Carcinomas (EAOC) - Epidemiological and Molecular Pathological Aspects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Basel, Switzerland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Basel, Switzerland</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine whether a relationship exists between a previously&#xD;
      established diagnosis of endometriosis and the consecutive risk of developing a clear cell or&#xD;
      endometrioid ovarian carcinoma. All histopathological records since 1980 with these diagnoses&#xD;
      (endometriosis, clear cell and endometrioid ovarian carcinoma) will be reviewed. Cancer&#xD;
      registry data will be assessed to investigate differences in survival of women with&#xD;
      endometriosis-associated ovarian carcinomas and those ovarian carcinoma patients without&#xD;
      previous diagnosis of endometriosis.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Actual">December 2013</completion_date>
  <primary_completion_date type="Actual">August 2013</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence and clinical outcome of endometriosis-associated ovarian carcinomas</measure>
    <time_frame>30 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">0</enrollment>
  <condition>Endometrioid Carcinoma</condition>
  <condition>Clear Cell Carcinoma</condition>
  <condition>Endometriosis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        primary care hospital, university hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  endometrioid ovarian carcinoma&#xD;
&#xD;
          -  clear cell ovarian carcinoma&#xD;
&#xD;
          -  endometriosis, atypical endometriosis&#xD;
&#xD;
          -  borderline tumors with endometriosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  undifferentiated carcinomas&#xD;
&#xD;
          -  germ cell tumors&#xD;
&#xD;
          -  sex cord-stromal tumors&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ellen Obermann, MD, Dr.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Basel, University of Basel</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Ellen C Obermann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institute of Pathology, University Hospital Basel, University of Basel</affiliation>
  </overall_official>
  <verification_date>March 2015</verification_date>
  <study_first_submitted>November 18, 2012</study_first_submitted>
  <study_first_submitted_qc>November 18, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 22, 2012</study_first_posted>
  <last_update_submitted>March 31, 2015</last_update_submitted>
  <last_update_submitted_qc>March 31, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 1, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
    <mesh_term>Ovarian Neoplasms</mesh_term>
    <mesh_term>Carcinoma, Ovarian Epithelial</mesh_term>
    <mesh_term>Adenomyoepithelioma</mesh_term>
    <mesh_term>Adenocarcinoma, Clear Cell</mesh_term>
    <mesh_term>Carcinoma, Endometrioid</mesh_term>
    <mesh_term>Endometriosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

